SCHEMBL6173224

SCHEMBL6173224

COc1ccc(-c2cc(C(C)C3NC(=O)N(c4ccc(S(=O)(=O)C(F)(F)F)cc4)C3=O)ccn2)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
PTGS2 P35354 13/20 0.36
PTGS1 P23219 7/20 0.36
IGF1R P08069 2/20 0.35
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAT2A P31153 1/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA5A P35218 1/20 0.32
CA5B Q9Y2D0 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6177752 0.91 IGF1R (0.37) LMNAPTGS2PTGS1IGF1R
SCHEMBL6173805 0.90 IGF1R (0.36) LMNAPTGS2PTGS1IGF1R
SCHEMBL6174756 0.88 MAT2A (0.43) LMNAKDM4EMAT2AMAPT
SCHEMBL6174486 0.86 IGF1R (0.38) LMNAIGF1RSMN1; SMN2MAT2A
SCHEMBL6174200 0.85 IGF1R (0.40) LMNAIGF1RMAT2A
SCHEMBL6177664 0.84 IGF1R (0.37) LMNAPTGS2PTGS1IGF1RKMT2A
SCHEMBL6176337 0.83 NPC1 (0.39) LMNAKDM4EALDH1A1TP53KMT2A
SCHEMBL6173577 0.82 IGF1R (0.39) LMNAIGF1RALDH1A1SMN1; SMN2
SCHEMBL6175008 0.82 IGF1R (0.39) LMNAIGF1RSMN1; SMN2
SCHEMBL6170257 0.81 IGF1R (0.39) LMNAPTGS2PTGS1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed